Literature DB >> 30683654

PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells.

Tao Chen1, Ting Wang2,3, Wenhua Liang1, Qin Zhao2, Qiujing Yu2, Chun-Min Ma2, Lingang Zhuo2, Dong Guo2, Ke Zheng2, Chengzhi Zhou1, Shupei Wei1, Wenhua Huang1, Juhong Jiang1, Jing Liu1, Shiyue Li1, Jianxing He4, Yuhui Jiang5, Nanshan Zhong1.   

Abstract

The metabolic activity of fumarase (FH) participates in gene transcription linking to tumor cell growth. However, whether this effect is implicated in lung cancer remains unclear. Here, we show TGFβ induces p38-mediated FH phosphorylation at Thr 90, which leads to a FH/CSL (also known as RBP-Jκ)/p53 complex formation and FH accumulation at p21 promoter under concomitant activation of Notch signaling; in turn, FH inhibits histone H3 Lys 36 demethylation and thereby promotes p21 transcription and cell growth arrest. In addition, FH is massively phosphorylated at the Ser 46 by PAK4 in non-small cell lung cancer (NSCLC) cells, and PAK4-phosphorylated FH binds to 14-3-3, resulting in cytosolic detention of FH and prohibition of FH/CSL/p53 complex formation. Physiologically, FH Ser 46 phosphorylation promotes tumorigenesis through its suppressive effect on FH Thr 90 phosphorylation-mediated cell growth arrest in NSCLC cells and correlates with poor prognosis in patients with lung cancer. Our findings uncover an uncharacterized mechanism underlying the local effect of FH on TGFβ-induced gene transcription, on which the inhibitory effect from PAK4 promotes tumorigenesis in lung cancer. SIGNIFICANCE: Fumarase counteracts CSL via its metabolic activity to facilitate TGFβ-induced cell growth arrest, an effect largely blocked by PAK4-mediated phosphorylation of fumarase. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30683654     DOI: 10.1158/0008-5472.CAN-18-2575

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases.

Authors:  Rakesh Kumar; Aswathy Mary Paul; Ravikumar Amjesh; Bijesh George; M Radhakrishna Pillai
Journal:  Cancer Metastasis Rev       Date:  2020-08-21       Impact factor: 9.264

Review 2.  Regulation of tumor metabolism by post translational modifications on metabolic enzymes.

Authors:  Abhisha Sawant Dessai; Poonam Kalhotra; Aaron T Novickis; Subhamoy Dasgupta
Journal:  Cancer Gene Ther       Date:  2022-08-23       Impact factor: 5.854

3.  Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells.

Authors:  Peilu Song; Fan Zhao; Dahong Li; Jiqiang Qu; Miao Yao; Yuan Su; Hanxun Wang; Miaomiao Zhou; Yujie Wang; Yinli Gao; Feng Li; Dongmei Zhao; Fengjiao Zhang; Yu Rao; Mingyu Xia; Haitao Li; Jian Wang; Maosheng Cheng
Journal:  Acta Pharm Sin B       Date:  2022-03-04       Impact factor: 14.903

4.  Linking metabolic and epigenetic regulation in the development of lung cancer driven by TGFβ signaling.

Authors:  Liyi Zhang
Journal:  AIMS Genet       Date:  2019-06-03

5.  Functions of metabolic enzymes in the development of non-small cell lung cancer.

Authors:  Gang Zhao
Journal:  Thorac Cancer       Date:  2019-08-01       Impact factor: 3.500

Review 6.  The Interplay Between TGF-β Signaling and Cell Metabolism.

Authors:  Huidong Liu; Ye-Guang Chen
Journal:  Front Cell Dev Biol       Date:  2022-03-09

Review 7.  p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.

Authors:  Xiaodong Li; Feng Li
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

Review 8.  Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.

Authors:  Martina Godel; Giacomo Ortone; Dario Pasquale Anobile; Martina Pasino; Giulio Randazzo; Chiara Riganti; Joanna Kopecka
Journal:  Pharmaceutics       Date:  2021-05-20       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.